Literature DB >> 26956126

Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial.

F Higashikawa1,2, M Noda1,2, T Awaya3, N Danshiitsoodol2, Y Matoba2, T Kumagai2, M Sugiyama1,2.   

Abstract

BACKGROUND/
OBJECTIVES: The population of the obese is increasing worldwide. Prevention and improvement of obesity are indispensable for decreasing the risk of metabolic disorders. We have recently shown that obesity and fatty liver are reduced by a plant-derived lactic acid bacterium, Pediococcus pentosaceus LP28 (LP28), in high-fat diet-induced obese mice. The aim of the present clinical study is to prove that LP28 is effective for reducing body fat and body weight, as shown in the experiment using mice. SUBJECTS/
METHODS: The clinical trial was carried out as a double-blind, randomized, placebo-controlled study comprising 62 subjects (20-70 years of age, BMI 25-30 kg/m(2)). These subjects were randomly assigned to three groups that received living LP28, heat-killed LP28 or a placebo powder, administered orally once a day for 12 weeks.
RESULTS: Heat-killed LP28 reduced BMI (0.45 kg/m(2), 95% CI (0.04, 0.86), P=0.035), body fat percentage (1.11%, (0.39, 1.82), P=0.002), body fat mass (1.17 kg (0.43, 1.92), P=0.004) and waist circumference (2.84 cm (0.74, 4.93), P=0.009) when compared with a placebo group. Fasting plasma glucose, HbA1c, fasting insulin, HOMA-IR and serum lipids levels did not change by either living LP28 or heat-killed LP28 intake.
CONCLUSIONS: Heat-killed LP28 displays an antiobesity effect that reduces BMI, body fat and waist circumference, suggesting that the plant-derived lactic acid bacterium LP28 would be a promising preventive of metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26956126     DOI: 10.1038/ejcn.2016.17

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  25 in total

1.  Gateway to the metabolic syndrome.

Authors:  Gema Medina-Gomez; Antonio Vidal-Puig
Journal:  Nat Med       Date:  2005-06       Impact factor: 53.440

Review 2.  Adipocytokines in obesity and metabolic disease.

Authors:  Haiming Cao
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

3.  Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

4.  Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.

Authors:  Kinori Kosaka; Mitsuihiko Noda; Takeshi Kuzuya
Journal:  Diabetes Res Clin Pract       Date:  2005-02       Impact factor: 5.602

5.  Improvement of constipation and liver function by plant-derived lactic acid bacteria: a double-blind, randomized trial.

Authors:  Fumiko Higashikawa; Masafumi Noda; Tomokazu Awaya; Kazuhiro Nomura; Hirotaka Oku; Masanori Sugiyama
Journal:  Nutrition       Date:  2009-07-22       Impact factor: 4.008

6.  Dose translation from animal to human studies revisited.

Authors:  Shannon Reagan-Shaw; Minakshi Nihal; Nihal Ahmad
Journal:  FASEB J       Date:  2007-10-17       Impact factor: 5.191

7.  Multiple Imputation: A Flexible Tool for Handling Missing Data.

Authors:  Peng Li; Elizabeth A Stuart; David B Allison
Journal:  JAMA       Date:  2015-11-10       Impact factor: 56.272

8.  The obesity and fatty liver are reduced by plant-derived Pediococcus pentosaceus LP28 in high fat diet-induced obese mice.

Authors:  Xingrong Zhao; Fumiko Higashikawa; Masafumi Noda; Yusuke Kawamura; Yasuyuki Matoba; Takanori Kumagai; Masanori Sugiyama
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

Review 9.  Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis.

Authors:  Savvas C Savva; Demetris Lamnisos; Anthony G Kafatos
Journal:  Diabetes Metab Syndr Obes       Date:  2013-10-24       Impact factor: 3.168

Review 10.  Role of adiponectin in metabolic and cardiovascular disease.

Authors:  Sewon Lee; Hyo-Bum Kwak
Journal:  J Exerc Rehabil       Date:  2014-04-30
View more
  26 in total

1.  Fermented Dairy Products, Probiotic Supplementation, and Cardiometabolic Diseases: A Systematic Review and Meta-analysis.

Authors:  Judit Companys; Laura Pla-Pagà; Lorena Calderón-Pérez; Elisabet Llauradó; Rosa Solà; Anna Pedret; Rosa M Valls
Journal:  Adv Nutr       Date:  2020-07-01       Impact factor: 8.701

Review 2.  Pediococcus pentosaceus: Screening and Application as Probiotics in Food Processing.

Authors:  Yining Qi; Le Huang; Yan Zeng; Wen Li; Diao Zhou; Jianhua Xie; Junyan Xie; Qiang Tu; Dun Deng; Jia Yin
Journal:  Front Microbiol       Date:  2021-12-16       Impact factor: 5.640

Review 3.  Probiotics' effect on visceral and subcutaneous adipose tissue: a systematic review of randomized controlled trials.

Authors:  Leonardo M Porchia; Gabriela Vazquez-Marroquin; Renata Ochoa-Précoma; Ricardo Pérez-Fuentes; M Elba Gonzalez-Mejia
Journal:  Eur J Clin Nutr       Date:  2022-04-13       Impact factor: 4.016

4.  Antioxidant potential of Pediococcus pentosaceus strains from the sow milk bacterial collection in weaned piglets.

Authors:  Leli Wang; Qihang Liu; Yuwei Chen; Xinlei Zheng; Chuni Wang; Yining Qi; Yachao Dong; Yue Xiao; Cang Chen; Taohong Chen; Qiuyun Huang; Zongzhao Zhai; Cimin Long; Huansheng Yang; Jianzhong Li; Lei Wang; Gaihua Zhang; Peng Liao; Yong-Xin Liu; Peng Huang; Jialu Huang; Qiye Wang; Huanhuan Chu; Jia Yin; Yulong Yin
Journal:  Microbiome       Date:  2022-06-01       Impact factor: 16.837

Review 5.  Relationships Among Gut Microbiota, Ischemic Stroke and Its Risk Factors: Based on Research Evidence.

Authors:  Qinhong Huang; Guannan Cai; Ting Liu; Zhihua Liu
Journal:  Int J Gen Med       Date:  2022-02-23

6.  Effects of Agave fructans (Agave tequilana Weber var. azul) on Body Fat and Serum Lipids in Obesity.

Authors:  Eduardo Padilla-Camberos; Carla P Barragán-Álvarez; Nestor E Diaz-Martinez; Vineet Rathod; José Miguel Flores-Fernández
Journal:  Plant Foods Hum Nutr       Date:  2018-03       Impact factor: 3.921

Review 7.  Obesity and microbiota: an example of an intricate relationship.

Authors:  Sabrina Duranti; Chiara Ferrario; Douwe van Sinderen; Marco Ventura; Francesca Turroni
Journal:  Genes Nutr       Date:  2017-06-15       Impact factor: 5.523

8.  Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Hana Koutnikova; Bernd Genser; Milena Monteiro-Sepulveda; Jean-Michel Faurie; Salwa Rizkalla; Jürgen Schrezenmeir; Karine Clément
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

9.  Choosing an appropriate probiotic product for your patient: An evidence-based practical guide.

Authors:  Jason C Sniffen; Lynne V McFarland; Charlesnika T Evans; Ellie J C Goldstein
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

Review 10.  Dietary Alteration of the Gut Microbiome and Its Impact on Weight and Fat Mass: A Systematic Review and Meta-Analysis.

Authors:  George Kunnackal John; Lin Wang; Julie Nanavati; Claire Twose; Rajdeep Singh; Gerard Mullin
Journal:  Genes (Basel)       Date:  2018-03-16       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.